Biogen (BIIB) Weeks-6 TECFIDERA Scripts Continue to Ramp

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. EAT
6. WYFI
7. STUB
8. SNDK
9. ARX
10. BTGO

May 20, 2013 10:06 AM EDT
Get Alerts BIIB Hot Sheet
Price: $210.65 --0%

Rating Summary:
    28 Buy, 15 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 9 | Down: 6 | New: 3
Join SI Premium – FREE
Sixth-week scripts for Biogen's (NASDAQ: BIIB) TECFIDERA increased 27% week-over-week.

Commenting, Leerink Swann analyst Marko Kozul said, "KOLs describe most early Tecfidera starts coming from patients switching from Avonex and especially Copaxone . . . These patients are generally switching due to 'injection site fatigue' as well as attraction to Tecfidera's oral administration."

Leerink Swann has an Outperform rating on Biogen with a price target of $230.00

For an analyst ratings summary and ratings history on Biogen (NASDAQ: BIIB) click here. For more ratings news on Biogen click here.

Shares of Biogen closed at $226.85 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View